The study was a single-arm, multicentre, prospective study enrolling 31 high-risk adult individuals with symptomatic mitral regurgitation despite optimal medical therapy from five institutions in Europe. The primary efficacy endpoints included: (a) Technical success rate of the device implantation; (b) Technical feasibility of Cardioband adjustment;
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Mitral valve disease
December 10, 2015
November 11, 2015
2 year outcomes of a randomized trial of MV repair vs MV replacement for severe ischemic MR are reported. LVESVI was similar between the two groups. Recurrent moderate or severe MR was higher in the repair group (59% vs 4%). The repair group suffered higher rates of heart failure and hospital readmission. Mortality rates were not different.
November 3, 2015
Since the 1990s, minimally invasive cardiac surgery has gained wide acceptance due to patient and economic demand. The advantages are less trauma, less bleeding, less wound infections, less pain and faster recovery. Many studies showed that the outcomes are comparable with those of conventional sternotomy.
October 20, 2015
This video presents a repair of a mitral valve in a 73-year-old man with history of PND and one episode of pulmonary edema. The patient suffered from severe eccentric mitral regurgitation due to ruptured chordae and a thickened enlarged P2 segment.
October 15, 2015
This video demonstrates the superior transeptal approach to the left atrium in a patient requiring mitral and tricuspid valve repairs.
October 8, 2015
The authors evaluated ventricular function after AR or MR in young patients with regurgitation and preoperative signs of ventricular dysfunction. Results at 18 mos were compared to a normal population. Persistent LV dysfunction was present in 85% after AR+MR and was more common than after either operation alone. Preoperative end-systolic volume pr
September 30, 2015
Ischemic mitral regurgitation (IMR) is a subset of functional mitral regurgitation (MR) that has the potential to impact an increasing number of patients in the future. This is in the context of a worldwide population, which continues to live longer with improved survival after myocardial infarction.
September 29, 2015
Vinnie Bapat of Guys and St. Thomas’ Hospital, London, UK, discusses the Edwards FORTIS device, a transcatheter mitral valve device.
September 28, 2015
This video shows a robotic-assisted repair of an anterior mitral valve leaflet perforation from endocarditis and ruptured posterior chordae tendinae.
September 24, 2015
Neil Moat of the Royal Brompton Hospital, London, UK, gives a talk on transcatheter mitral valve implantation.